This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The 144-page report, compiled by the Cannabis Regulation Oversight Office (CROO), incorporates data from several state departments. During Fiscal Year 2025, “IDFPR is anticipating inspecting and approving to open approximately 80 additional dispensaries from the 2021 lotteries. Find detailed information about this topic here.)
Fernando Fandio-Sende, LifeCannMD After thirty years practicing medicine and specializing as a Miami cannabis doctor , I’ve had countless conversations with patients who tell me the same thing: “Doctor, I want to try medical marijuana , but I’m scared of getting too high.”
These cost-control measures hurt everyone, but they especially impact medical patients who rely on specific strains and more expensive, hard-to-DIY products like concentrates to potentially treat their symptoms without coverage from healthcare providers.
On July 1, 2021, medical marijuana became legal in South Dakota. A medical patient could end up in jail for possessing even small amounts of marijuana. Despite the 70% voter and MPP support of medical cannabis in South Dakota, Governor Noem still attempted to delay the medical cannabis law by another year in 2021.
Drug company Lykos Therapeutics, which had filed the new drug application for MDMA therapy , was informed by the US Food and Drug Administration (FDA) that the data submitted was insufficient to receive approval, requesting that the company conduct an additional Phase 3 trial to further test the safety and efficacy of the drug.
According to data from the Virginia Criminal Sentencing Commission, more than 15,000 people were convicted for a first or second marijuana possession offense from July 2018 to June 2019. The program is expected to be operational and dispensing cannabis products to authorized patients by mid-year.
According to data from the Virginia Criminal Sentencing Commission, more than 15,000 people were convicted for a first or second marijuana possession offense from July 2018 to June 2019. The program is expected to be operational and dispensing cannabis products to authorized patients by mid-year.
MoreBetter, creators of the Releaf App, is using this real world data to push back against the claim that there’s no evidence that CBN can help people sleep. In 2021, MoreBetter used its web-based software to track over 350 people using a CBN tincture from CBDistillery. It also, allegedly, helps with sleep (more on that below).
Just about any industry benefits greatly from the proper use and evaluation of data. The tech giants of today are built mostly on data regarding their users, and advertisers rely on that data to more effectively target their efforts. How to Use the Data. RYAH Group Inc.
Listen & Subscribe: Finding the right cannabis product can be a daunting task for anyone, let alone a new medical patient without any guidance. Anonymized data also helps scientists better understand the cannabis plant and what products and chemical profiles are most effective for treating different conditions and symptoms.
In nursing school, I wrote my dissertation on the role of the nurse when caring for patients using cannabis therapeutically, knowing that nurses are often the first healthcare professional to whom patients disclose their cannabis use. I remain in awe of these patients to this day.
On July 1st, 2021, new cannabis legalization are going into effect in Connecticut, New Mexico, and Virginia, just a couple days after a recreational cannabis legalization measure went into effect in South Dakota. As of July 1, 2021, all five states had both adult-use and medical cannabis programs. ? In Colorado, 78.7%
– Drug Demonstrates Efficacy and Safety in Advanced Prostate Cancer Patients. NEW YORK , June 4, 2021 /PRNewswire/ — AIkido Pharma Inc. Nasdaq: AIKI ) (“AIkido” or the “Company”) today announced that positive Phase 1 testing data was presented at the 2021 ASCO Annual Meeting June 4 , 2021.
PsyTech uses data-driven tools that allow physicians insight into patient well-being and clinical best practices. Empower Clinics reported total revenues of $2 million in the first quarter of 2021. The post Psychedellux July 16, 2021 appeared first on Green Market Report. also known as PsyTech Inc., PharmaDrug Inc.
State legislators in 2021 enacted over 50 laws liberalizing marijuana policies in more than 25 states, according to a report issued today by the National Organization of the Reform of Marijuana Laws (NORML). 2021 was a significant year for marijuana policy reform. The law took effect on July 1, 2021. FULL REPORT. New Jersey.
On top of recognizing the vast scope of benefits cannabis can provide, patients are saving lots of hard-earned money by swapping their pills for cannabis. The team that conducted the study looked at stock return and prescription drug sales data for 556 pharmaceutical companies. Why Patients Are Choosing MMJ Over Pharmaceuticals.
September 09, 2021. I certainly hope that other states follow Nevada’s lead and provide reassurances to licensed veterinarians that they can administer CBD or talk about it with patients without fear of facing disciplinary proceedings,” he said. But do medical cannabinoids actually help animal patients? Earlier this year, Gov.
Are you able to answer your patients’ medical marijuana questions? and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’ million medical marijuana patients nationwide. Written by Dr. Meredith Fisher-Corn, MD , Editor-in-Chief at TheAnswerPage.com.
Net loss for the six months ended 30 June 2021 was $30.2 Net loss for the six months ended 30 June 2021 was $30.2 Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. On track to report top-line data by end of 2021.
Medicinal Cannabis Access Data Dashboard. 19 August 2021. To improve transparency and data accessibility, the TGA publishes de-identified data on the number of unapproved medicinal cannabis products accessed through the Special Access Scheme (SAS). Medicinal cannabis Special Access Scheme category B data.
No data exists on how many registered medical patients are actively growing cannabis in Illinois. Though many reasons factor into the number of patients who grow and why, two trendlines that are heading in opposite direction may suggest more medical cannabis patients in Illinois are opting to grow their own medicine.
New data shows MYMD-1 has key differentiators and capabilities compared to existing TNF inhibitor drugs. Data also demonstrated that none of the biological drugs selected for the comparison study proved to be anti-proliferative to any of the primary cell types assessed. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc.
was less than total sales from 2021 and 2020. Although August total medical cannabis sales is estimated because of an uncorrected IDPH data entry error, Illinois medical cannabis sales for 2022 should be around $353 million. This total is a decrease from 2021 yearly totals of $397,249,781.70 2021 totals: $397,249,781.70.
A new report by New Frontier Data estimated that U.S. legal and illicit cannabis consumer spending reached an estimated US$97 billion in 2021, according to a new report by New Frontier Data. legal and illicit sales in 2021, cannabis consumer spending now exceeds spirits ($86 billion), validating the vast market opportunity.
We increased the dosage to two doses of IGC-AD1 per day in Cohort 2, which was conducted from early February 2021 through mid-May 2021. The Phase 1 clinical trial on Alzheimer’s patients is currently anticipated to conclude during the July through September 2021 timeframe.
Data Snapshot: Cannabis Consumer Spending and Trends: James Ahrendt , Business Intelligence Architect, Akerna. We carefully curate this data and research-based report for anyone interested in gaining a better understanding of the fastest-growing industry in the world,” says Jessica Billingsley , Akerna Chief Executive Officer. “We
Unlike most other ailments, there isn’t a simple test that physicians can use to diagnose a patient with a disorder. CSE: MXT) (OTCQB: MXTTF) aims to address these problems by pairing biometric interviews with brainwave data to create a proprietary mental health reference database. (CSE: Source: Data Bridge.
July 5, 2021 – July 9, 2021. CSE: MSET) revealed additional preclinical data showing strong efficacy and improved safety in a head-to-head comparison with psilocybin. PsyIndex Weekly Update. The PsyIndex moved marginally lower last week, giving up some gains from the prior week. Market Performance. Powered by.
HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. in 2021 reached $2 billion, according to Statistica.)
June 7, 2021 – June 11, 2021. OTCQB: SILO) announced a collaboration with UCSF to study psilocybin as an anti-inflammatory agent in Parkinson’s and bipolar patients. Market Performance. Weekly Performance: $140.44 (15.04%). Powered by. CFN Enterprises Inc. OTCQB: CNFN). World Psychedelics Day. (CSE: Press Release.
A panel of Commonwealth Court judges has ordered the Wolf administration to reveal how many medical marijuana patients have received approval from a doctor to use cannabis for opioid addiction treatment. The newsroom specifically requested aggregate data — information that would not identify individual patients.
In July, 2021, Israeli lawmakers rejected a bill that would have decriminalized recreational marijuana use. The Israeli government formally legalized medical marijuana in 1999, and by 2020 the number of registered patients reached a record high of over 70,000. This unit then makes a decision about whether or not to issue the permit.
reported a data breach stemming from a misconfigured web application that caused personal information to be accessible on the company’s website. On June 17, 2022, Silverstreak filed an official notice of the breach and sent out data breach letters to all affected parties. What We Know About the Silverstreak Solutions Data Breach.
WHILE Italy is both one of the earliest and largest medical cannabis markets in Europe, new data has revealed the ongoing inability of its system to ‘serve patients’ needs’. The Italian Military’s Monopoly On Medical Cannabis Production Is Strangling Market Growth New Data Suggests. Undersupply. Read full article.
GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older. ADDITIONAL INFORMATION.
The Core Business delivered strong organic growth 13 in H1 2021 (17% year-on-year) despite some of Eurofins’ businesses remaining affected by lockdowns during H1 2021. The Core Business delivered strong organic growth 13 in H1 2021 (17% year-on-year) despite some of Eurofins’ businesses remaining affected by lockdowns during H1 2021.
More than 100 people in the US have been hospitalized in 2021 after using Delta-8 THC products, federal health regulators warned Tuesday. Of the 22 patients, 19 experienced adverse events after ingesting delta-8 THC-containing food products (e.g., 39% involved pediatric patients less than 18 years of age. brownies, gummies).
TORONTO, June 01, 2021 (GLOBE NEWSWIRE) — via InvestorWire – RYAH Group, Inc. The 5-year study is expected to cover tens of thousands of patients suffering from chronic pain, which makes it one of the largest and most ambitious research projects to be conducted in the plant-based treatment arena. About RYAH Group, Inc.
On April 19, 2021, construction began on three buildings, one retail and two industrial, totaling approximately 63,000 square feet. According to a New Frontier Data Report, the overall legal cannabis industry in America is valued at roughly $13.2 Goodblend expects to complete the project near the beginning of next year.
TORONTO, June 23, 2021 (GLOBE NEWSWIRE) — RYAH Group, Inc. Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. billion, servicing nearly 340,000 active patients. in real terms to £4.97
The results of the clinical trial have been submitted in the Clinical/Statistical Report (“CSR”) filed with the FDA, and relevant data is also available on Form 8-K filed with the SEC on December 2, 2021. Over 70% of these patients face one or more debilitating symptoms, including anxiety, depression, and agitation (Mendez, 2021).
While Michigan has undergone a price rout in 2021, with wholesale flower prices falling nearly $500 per pound, the state is virtually guaranteed to attract business from neighboring Ohio where medical cannabis is legal, but prices are significantly higher. per ounce, equivalent to an average retail price for patients of $4,610 per pound.
As of start of business Wednesday, September 1, the Commission reported licensees have generated $844 million since January 1, already making 2021 a record sales year thus far. The Commission’s overall staff has increased to 84 employees, with 17 new employees joining the agency in 2021 and spanning nearly every department.
Headset , a data platform for the cannabis economy, recently released a report that examined the Illinois cannabis market. According to Headset, “This report analyzes detailed data on thousands of products in the Illinois market to determine how it compares to other states. compared to 17.3% nationally.” on June 1, 2023.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content